Poulin R, Secrist J A, Pegg A E
Department of Physiology, Milton S. Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey 17033.
Biochem J. 1989 Oct 1;263(1):215-21. doi: 10.1042/bj2630215.
1-Amino-oxy-3-aminopropane (AOAP) was reported to inhibit several mammalian polyamine-biosynthetic enzymes in vitro, including ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (AdoMetDC) [Khomutov, Hyvönen, Karvonen, Kauppinen, Paalanen, Paulin, Eloranta, Pajula, Andersson & Pösö (1985) Biochem. Biophys. Res. Commun. 130, 596-602]. In order to clarify its mechanism of action in intact cells, the inhibitory properties of AOAP on the growth and polyamine metabolism of L1210 cells were compared with those seen in a variant subline (D-R cells) which overproduces ODC. As little as 20 microM-AOAP completely blocked proliferation of L1210 cells, and this effect was reversed by the concomitant addition of exogenous putrescine or spermidine. Growth of D-R cells was not affected by AOAP at concentrations up to 0.5 mM. There was no difference in the uptake of AOAP between the L1210 and the D-R cells. Exposure of L1210 or D-R cells to AOAP greatly decreased ODC activity in undialysed cell extracts, but did not decrease AdoMetDC. Activities of both enzymes were increased severalfold by AOAP treatment when activity was measured in dialysed extracts. Treatment with AOAP depleted intracellular putrescine and spermidine contents of L1210 cells, while inducing a massive accumulation of decarboxylated AdoMet. The 8-fold higher putrescine pool present in untreated D-R cells was depleted in a dose-dependent manner by AOAP, but a significant decrease in spermidine and accumulation of decarboxylated AdoMet required 10 times higher drug concentrations, and the changes were much less dramatic than in L1210 cells. These results indicate that in L1210 cells AOAP behaves primarily as a reversible inhibitor of ODC.
据报道,1-氨基氧基-3-氨基丙烷(AOAP)在体外可抑制多种哺乳动物的多胺生物合成酶,包括鸟氨酸脱羧酶(ODC)和S-腺苷甲硫氨酸脱羧酶(AdoMetDC)[霍穆托夫、许沃宁、卡尔沃宁、考皮宁、帕拉宁、保林、埃洛兰塔、帕尤拉、安德森和波索(1985年),《生物化学与生物物理研究通讯》130,596 - 602]。为了阐明其在完整细胞中的作用机制,将AOAP对L1210细胞生长和多胺代谢的抑制特性与在过量产生ODC的变异亚系(D-R细胞)中观察到的特性进行了比较。低至20微摩尔/升的AOAP就能完全阻断L1210细胞的增殖,同时添加外源性腐胺或亚精胺可逆转这种作用。浓度高达0.5毫摩尔/升的AOAP对D-R细胞的生长没有影响。L1210细胞和D-R细胞对AOAP的摄取没有差异。将L1210或D-R细胞暴露于AOAP会使未透析的细胞提取物中的ODC活性大大降低,但不会降低AdoMetDC的活性。当在透析提取物中测量活性时,AOAP处理会使两种酶的活性增加几倍。用AOAP处理会耗尽L1210细胞内的腐胺和亚精胺含量,同时诱导脱羧AdoMet大量积累。未处理的D-R细胞中高出8倍的腐胺池被AOAP以剂量依赖的方式耗尽,但亚精胺的显著降低和脱羧AdoMet的积累需要高出10倍的药物浓度,而且这些变化比在L1210细胞中要小得多。这些结果表明,在L1210细胞中,AOAP主要表现为ODC的可逆抑制剂。